Oncologix Tech Inc (OCLG)

[gibbon1]

Well that is a complicated question. If float is under 100 million creating more liquidity will help in the long run. But it will hurt short term. Exposure and increased profit along with lowering debt will fundamentally make the company strong but when the share structure is off things can be wacky for a minute. Obviously acquiring some more long term shareholders will be valuable. But we need long term shareholders that invest in biotech companies and the company needs to promote with site like biomedreports to attract those types of shareholders. As it is right now OCLG is just a ticker sitting out there in a see of other tickers. Just because a 100 shareholders may know about it is not saying much we need 1000s of shareholders to know who we are and biomedreports is the only way to go to acquire that. OCLG